Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

CARI ONE helps start hair growth and makes hair follicles bigger and more numerous.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

BST2 protein and certain T cells increase in early alopecia areata.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Immune cells might contribute to hair loss caused by a specific mutation.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

People with acne have more CD4+ immune cells in their skin than healthy people.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Special cells can help regrow hair in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.